📊 ECIA Key Takeaways
Is ECIA a Good Investment? Thesis Analysis
Encision Inc faces severe operational challenges with negative operating margins (-8.9%), negative net margins (-9.9%), and deteriorating profitability despite maintaining a healthy gross margin of 50.3%. The company is burning cash with negative operating cash flow (-$242.1K) and negative free cash flow (-$285.4K), while cash reserves are critically low at $71.7K, creating substantial solvency risk. Revenue contraction (-0.5% YoY) combined with inability to achieve profitability indicates fundamental business model stress.
Why Buy ECIA? Key Strengths
- Solid gross margin of 50.3% indicates reasonable pricing power and cost of goods control
- Healthy current ratio of 2.28x suggests adequate short-term liquidity for immediate obligations
- Low leverage with debt-to-equity ratio of 0.08x provides minimal default risk from debt obligations
ECIA Investment Risks to Consider
- Critical cash burn with negative operating cash flow and dangerously low cash balance ($71.7K) creates imminent liquidity crisis
- Persistent unprofitability with negative operating income (-$278.3K) and negative net income (-$309.0K) indicates operational dysfunction
- Revenue stagnation (-0.5% YoY) combined with inability to control operating expenses suggests deteriorating competitive position in medical device sector
- Negative interest coverage ratio (-4.5x) indicates inability to service debt obligations from operations
- Zero insider buying activity in last 90 days suggests lack of management confidence in company prospects
Key Metrics to Watch
- Operating cash flow trend - any further deterioration accelerates insolvency risk
- Cash balance depletion rate and runway to require financing or restructuring
- Revenue stabilization and operating expense reduction to achieve profitability inflection
- Gross margin sustainability as potential indicator of market competitiveness
ECIA Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.28x current ratio provides a solid financial cushion.
ECIA Profitability Ratios
ECIA vs Healthcare Sector
How ENCISION INC compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is ECIA Overvalued or Undervalued?
Based on fundamental analysis, ENCISION INC has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
ECIA Balance Sheet & Liquidity
ECIA 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: ENCISION INC's revenue has declined by 14% over the 5-year period, indicating business contraction. The most recent EPS of $-0.06 indicates the company is currently unprofitable.
ECIA Growth Metrics (YoY)
ECIA Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $1.5M | -$148.2K | $-0.01 |
| Q1 2026 | $1.6M | $22.0K | $0.00 |
| Q3 2025 | $1.6M | -$24.7K | $0.00 |
| Q2 2025 | $1.8M | -$7.5K | $0.00 |
| Q1 2025 | $1.6M | $22.0K | $0.00 |
| Q3 2024 | $1.6M | -$207.1K | $-0.02 |
| Q2 2024 | $1.7M | -$7.5K | $0.00 |
| Q1 2024 | $1.7M | -$140.5K | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ECIA Capital Allocation
ECIA SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for ENCISION INC (CIK: 0000930775)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ECIA
What is the AI rating for ECIA?
ENCISION INC (ECIA) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are ECIA's key strengths?
Claude: Solid gross margin of 50.3% indicates reasonable pricing power and cost of goods control. Healthy current ratio of 2.28x suggests adequate short-term liquidity for immediate obligations.
What are the risks of investing in ECIA?
Claude: Critical cash burn with negative operating cash flow and dangerously low cash balance ($71.7K) creates imminent liquidity crisis. Persistent unprofitability with negative operating income (-$278.3K) and negative net income (-$309.0K) indicates operational dysfunction.
What is ECIA's revenue and growth?
ENCISION INC reported revenue of $3.1M.
Does ECIA pay dividends?
ENCISION INC does not currently pay dividends.
Where can I find ECIA SEC filings?
Official SEC filings for ENCISION INC (CIK: 0000930775) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ECIA's EPS?
ENCISION INC has a diluted EPS of $-0.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ECIA a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, ENCISION INC has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ECIA stock overvalued or undervalued?
Valuation metrics for ECIA: ROE of -16.6% (sector avg: 15%), net margin of -9.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ECIA stock in 2026?
Our dual AI analysis gives ENCISION INC a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ECIA's free cash flow?
ENCISION INC's operating cash flow is $-242.1K, with capital expenditures of $43.2K. FCF margin is -9.1%.
How does ECIA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -9.9% (avg: 12%), ROE -16.6% (avg: 15%), current ratio 2.28 (avg: 2).